Orient Pharma
FDA Approved Drugs

Orient Pharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 14
  • Latest Approval Date Jun 09, 2026
  • Data Source FDA
  • First Approval Date Oct 28, 2014
Company Overview

Company

Orient Pharma

Country

Taiwan

Website

Visit Website

Email

op@oppharma.com

Social Profiles

Company Snapshot

Orient Pharma

2F, No. 368, Sec. 1 Fu Hsing S. Road,Taipei 106

Taiwan

www.oppharma.com/index.php/eng/index op@oppharma.com View on Map
FDA Approved Drug Records ( 14 records )
2014
28 Oct
RX Application: 205085

Drug Name

CARISOPRODOL

Product Number

1

Dosage Form

-

Strength

350MG

Approval Date

2014-10-28

205085 / 1

Active Ingredient

CARISOPRODOL

Application Number

205085

Product Number

1

Dosage Form

-

Strength

350MG

Approval Date

2014-10-28

Regulatory Status

RX

2022
13 Sep
RX Application: 215693

Drug Name

EZETIMIBE

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2022-09-13

215693 / 1

Active Ingredient

EZETIMIBE

Application Number

215693

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2022-09-13

Regulatory Status

RX

2019
22 Feb
RX Application: 206483

Drug Name

GLYBURIDE

Product Number

1

Dosage Form

-

Strength

1.25MG

Approval Date

2019-02-22

206483 / 1

Active Ingredient

GLYBURIDE

Application Number

206483

Product Number

1

Dosage Form

-

Strength

1.25MG

Approval Date

2019-02-22

Regulatory Status

RX

2019
22 Feb
RX Application: 206483

Drug Name

GLYBURIDE

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2019-02-22

206483 / 2

Active Ingredient

GLYBURIDE

Application Number

206483

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2019-02-22

Regulatory Status

RX

2019
22 Feb
RX Application: 206483

Drug Name

GLYBURIDE

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2019-02-22

206483 / 3

Active Ingredient

GLYBURIDE

Application Number

206483

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2019-02-22

Regulatory Status

RX

2015
24 Feb
RX Application: 203965

Drug Name

MIGLITOL

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2015-02-24

203965 / 1

Active Ingredient

MIGLITOL

Application Number

203965

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2015-02-24

Regulatory Status

RX

2015
24 Feb
RX Application: 203965

Drug Name

MIGLITOL

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2015-02-24

203965 / 2

Active Ingredient

MIGLITOL

Application Number

203965

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2015-02-24

Regulatory Status

RX

2015
24 Feb
RX Application: 203965

Drug Name

MIGLITOL

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2015-02-24

203965 / 3

Active Ingredient

MIGLITOL

Application Number

203965

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2015-02-24

Regulatory Status

RX

2017
03 Feb
RX Application: 205932

Drug Name

PITAVASTATIN CALCIUM

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2017-02-03

205932 / 1

Active Ingredient

PITAVASTATIN CALCIUM

Application Number

205932

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2017-02-03

Regulatory Status

RX

2017
03 Feb
RX Application: 205932

Drug Name

PITAVASTATIN CALCIUM

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2017-02-03

205932 / 2

Active Ingredient

PITAVASTATIN CALCIUM

Application Number

205932

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2017-02-03

Regulatory Status

RX

2017
03 Feb
RX Application: 205932

Drug Name

PITAVASTATIN CALCIUM

Product Number

3

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2017-02-03

205932 / 3

Active Ingredient

PITAVASTATIN CALCIUM

Application Number

205932

Product Number

3

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2017-02-03

Regulatory Status

RX

2026
09 Jun
RX Application: 219830

Drug Name

TOFACITINIB CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 11MG BASE

Approval Date

2026-06-09

219830 / 1

Active Ingredient

TOFACITINIB CITRATE

Application Number

219830

Product Number

1

Dosage Form

-

Strength

EQ 11MG BASE

Approval Date

2026-06-09

Regulatory Status

RX

2019
29 Apr
RX Application: 210729

Drug Name

VANCOMYCIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 125MG BASE

Approval Date

2019-04-29

210729 / 1

Active Ingredient

VANCOMYCIN HYDROCHLORIDE

Application Number

210729

Product Number

1

Dosage Form

-

Strength

EQ 125MG BASE

Approval Date

2019-04-29

Regulatory Status

RX

2019
29 Apr
RX Application: 210729

Drug Name

VANCOMYCIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2019-04-29

210729 / 2

Active Ingredient

VANCOMYCIN HYDROCHLORIDE

Application Number

210729

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2019-04-29

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    14 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
14 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CARISOPRODOL

Application Number

205085

Product Number

1

Active Ingredient

CARISOPRODOL

Dosage Form

-

Strength

350MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit